Replies to post #658922 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

You are still trying to feel relevant by trying to initiate a reply from anyone. Sorry I cannot help you.

[TTsr]

EX, thanks for finally admitting that DCVax-L or ATL-DC are one in the same! TY!

[flipper44]

https://www.researchsquare.com/article/rs-2591941/v1

[The Danish Dude]

The Nature article to be published

https://www.researchgate.net/publication/373868111_Dendritic_Cell_Vaccination_in_Conjunction_with_a_TLR_Agonist_Polarizes_Interferon_Immune_Responses_in_Malignant_Glioma_Patients

Mentions this clinical trial with poly-iclc

https://clinicaltrials.gov/study/NCT01204684

And waddayaknow ... Northwest Biotherapeutics

Oncovir lists 10 P1/2 trials on their main page, and none of those is DCVax-L or ATL-DC.

Your bullshit is no currency other places than fud city.

Merry Greedness Judas

[biosectinvestor]

That is irrelevant, the initial introduction footnotes to Dr. Liau’s work on DCVax-L, including the interim results publication and the publication of the final Phase 3 results in JAMA Onc. NWBO is not a sponsor but her work on the vaccine is cumulative, and over time. The notion that she starts every test effort and variation with an entirely new vaccine despite getting great and intended results with the vaccine they started with is a bizarre notion that only shorts would suggest as if it were a serious discussion point.

The UCLA work stream is determined, focused and scientifically rational, not fickle and nonsensical, as shorts would constantly suggest.